Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in LPCN — Lipocine Inc.

CIK 1214717 BOSTON, MA
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$190,660
-$313,787 QoQ
Shares Held
74,477
+18.0% QoQ
Ownership
0.903%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. LPCN ranks #405 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in LPCN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $190,660 74,477
2026-03-31 $504,447 63,135
2025-12-31 $501,473 62,450
2025-09-30 $174,066 61,076
2025-06-30 $192,999 61,076
2025-03-31 $187,091 58,834
2024-12-31 $280,423 57,464
2024-09-30 $243,429 54,216
2024-06-30 $438,194 53,179
2024-03-31 $254,040 48,854
2023-12-31 $136,302 48,854
2023-09-30 $145,584 48,854
2023-06-30 $246,103 48,830
2023-03-31 $263,960 830,063
2022-12-31 $330,365 830,063
2022-09-30 $374,435 832,079
2022-06-30 $666,495 832,079
2022-03-31 $1,127,585 823,055
2021-12-31 $817,014 824,434
2021-09-30 $898,633 824,434
2021-06-30 $1,064,820 760,586
2021-03-31 $911,606 603,713
2020-12-31 $613,078 450,793
2020-09-30 $423,795 300,564
2020-06-30 $251,737 199,792
2020-03-31 $95,900 199,792